• ABOUT ELITE
    • Overview
    • Our Facility
    • Management & Key Employees
    • Our Board
    • Careers
  • PRODUCTS
  • PIPELINE
    • Generic
    • Branded
  • TECHNOLOGY
    • Technology Overview
    • How It Works
    • One Bead System
    • Two Bead System
  • INVESTOR RELATIONS
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Shareholder Meeting
    • Governance Documents
    • Investor Contacts
    • Email Alerts
logo image
HOME | CAREERS | CONTACT | NEWS |
Share
Skip to content
  • About Elite
    • Overview
    • Management & Key Employees
    • Our Board
    • Careers
  • Products
  • Pipeline
    • Generic
    • Branded
  • Technology
    • Technology Overview
    • How It Works
    • One Bead System
    • Two Bead System
  • Investor Relations
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Shareholder Meeting
    • Governance Documents
    • Investor Contacts
    • Email Alerts
    • Investor Relations
    • Press Releases
    • Events &
      Presentations
    • SEC Filings
    • Shareholder
      Meeting
    • Governance
      Documents
    • Investor Contacts
    • Email Alerts

Press Releases

 
Select:
Feb 28, 2007
Elite to Present at the Oppenheimer "Positioning Investors for the Next Wave in Pain Management" Conference in New York City on March 6, 2007

Feb 15, 2007
Elite Pharmaceuticals Provides Positive Clinical Update

Feb 14, 2007
Elite Pharmaceuticals Appoints Chief Scientific Officer

Dec 20, 2006
Elite Pharmaceuticals and ECR Launch Second Once-Daily Antihistamine LODRANE 24D®,Second Product Utilizing Elite's Drug Delivery Technology

Dec 13, 2006
Elite Pharmaceuticals Appoints a Prominent Specialty Pharmaceutical Executive, Dr. Veerappan Subramanian, to its Board of Directors and Engages Dr. Subramanian as Strategic Advisor

Nov 30, 2006
ELITE TO PRESENT AT BANK OF MONTREAL'S 2006 FOCUS ON HEALTHCARE CONFERENCE ON DECEMBER 7, 2006

Oct 27, 2006
ELITE HOLDS CLINICAL GUIDANCE MEETING WITH THE FDA ON ITS ABUSE DETERRENT PAIN PROGRAM

Sep 12, 2006
Elite Pharmaceuticals Provides Update on Company's Progress and Projected Milestones

Sep 06, 2006
Elite Pharmaceuticals Receives Approval from Independent Review Board to initiate Phase II Clinical Trial for Abuse Resistant Drug Product

Aug 31, 2006
ELITE TO PARTICIPATE IN ROTH CAPITAL'S 2006 NEW YORK CONFERENCE

 18   19   20   21   22     23    24   25   26   27   28 
 <<   <   >   >> 
  • Site Map   |  Privacy  |  Terms Of Use
Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.
ART™: Abuse-Resistant Technology for a safer healthier you.
Back to top

Privacy
Resize Viewer - Reduce Resize Viewer - Expand Close window